NeuroThera Labs Reports Progress in FDA-Approved Tourette Syndrome Trial
NeuroThera Labs announced further progress in its FDA-approved Phase IIb clinical trial for Tourette syndrome.
Story updates
12:12:53 PM UTC
SquawkNews
NeuroThera Labs completed manufacturing and secured European QP batch release for SCI-110, enabling drug shipment and patient enrollment preparations for its FDA-approved Phase IIb Tourette syndrome trial at three sites.Material DetailsContext by AI AnalystThis is an operational step in an early-to…